@versameb

Versameb AG is a privately held company focusing on discovering and developing innovative RNA-based drugs for indications of unmet medical need.

 Basel, Switzerland
versameb.com/
Joined January 2021
  • Tweets93
  • Following265
  • Followers65
46Media
𝗩𝗲𝗿𝘀𝗮𝗺𝗲𝗯 CEO Klaas Zuideveld joins Sabine Hutchison from @SeussPlus on Cut the Chat to talk RNA therapies for stress urinary incontinence—and why women’s health needs more attention and funding. 🎧 📺Full episode on Spotify: lnkd.in/d35Ghf7e #WomensHealth #mRNA
22
🎉Versameb AG secures its first patent in China for signal peptide technology! This milestone advances RNA-based therapeutics, improving protein delivery and expression. Proud of our team's dedication to innovation. See versameb.com/versameb-announ…. #Versameb #mRNA #Innovation #Patent
24
🌟Join us this International Women’s Day in spotlighting a crucial issue affecting millions of women worldwide: Stress Urinary Incontinence (SUI). At @versameb, we are committed to revolutionizing SUI treatment, empowering women worldwide to reclaim control of their lives.
1
1
167
more replies
🔬Our dedicated team is advancing an innovative treatment for SUI, aiming to restore physiological bladder function and provide long-term relief. But we can't do it alone – we need your support!
1
161
💪Together, let's break barriers in SUI treatment and empower women worldwide. Follow our journey and join the cause this International Women’s Day. #EmpoweringWomen #BreakingBarriers #SUITreatment #Versameb #InternationalWomensDay #incontinence #RNATherapeutics
133
@versameb is pleased to announce the publication of data in Molecular Therapy - Nucleic Acids Journal. The manuscript reveals how our innovative approach to #mRNA therapeutics has the potential to transform the landscape of regenerative medicine. versameb.com/versameb-announ…
3
474
@versameb is pleased to name Dr. Alexandre LeBeaut as Chair of its Board of Directors. Dr. LeBeaut has over two decades of global R&D leadership experiences, successfully bringing multiple medicines to market. Read the full PR, here: versameb.com/versameb-names-… #CompanyGrowth #mRNA
1
165
PRESS RELEASE 👉 Touchlight’s enzymatic doggybone DNA used in the manufacture of @versameb’s VMB-100 for first-in-human clinical study. Read the full press release here - touchlight.com/news/doggybon…
1
1
222
@versameb is delighted to announce FDA clearance of IND Application for its lead candidate VMB-100 in the treatment of stress urinary incontinence (SUI). Read more here: versameb.com/versameb-announ… #FDA #IND #urology #SUI #incontinence #mRNA #clinicaldevelopment

Versameb AG Announces FDA Clearance of IND Application for VMB-100 in the Treatment of Stress...

PRESS RELEASE | Basel, Switzerland, November 16, 2023 Versameb AG (“Versameb”), a pre-clinical stage company focused on transforming RNA therapeutics to treat unmet medical needs, today announced...

versameb.com
4
1
4
457
Congratulations @kkariko and Dr Drew Weissman, who where jointly awarded the @NobelPrize 2023 by The Nobel Assembly for their discoveries concerning nucleoside base modifications that enabled the development of effective #mRNA vaccines against #COVID-19.
1
1
117
@versameb's lead candidate VMB-100, a potential treatment for #SUI, is edging closer to #clinicaldevelopment. Read more about its potential to transform women's health outcomes in @DDWJournal: bit.ly/47qQehi
1
3
152
Our Chief Medical Officer, Roger Dmochowski, will be attending the @icsoffice (International Continence Society) Annual Meeting in Toronto this week, 27-29 September. Follow @versameb to explore the latest insights and advancements in #incontinence care. See you there!
1
3
580
This #UrologyAwarenessMonth, @versameb aims to raise awareness about Stress Urinary Incontinence (#SUI), a very common problem, with a detrimental impact on everyday life for countless women worldwide. Find out more on the @Labiotech_eu podcast: bit.ly/4441k91
1
2
65
Our CMO, Professor Roger Dmochowski, is a world-leading KOL in female urology and urologic reconstruction. Roger discusses the potential of mRNA therapeutics in the treatment of #SUI with @DrugTargetRev here: bit.ly/45g1ECw #UAM23
1
3
59
#SUI impacts millions worldwide, with no approved drug treatment that restores physiological #bladder function. Listen to the @versameb team speak about their plans to revolutionize SUI therapy on the @OptimumComms podcast: lnkd.in/eUiY99np #UAM23
1
3
158
September is #UrologyAwarenessMonth supported by @versameb which is committed to finding an effective treatment for Stress Urinary Incontinence (#SUI). Hear CEO, Klaas Zuideveld, discuss the potential of mRNA therapeutics in a recent @DDWJournal webinar: bit.ly/450BlAN
1
5
114
Our CEO, Klaas Zuideveld was a featured speaker at the latest @DDWJournal webinar entitled "Where are the breakthroughs in mRNA drug discovery and Link to webinar here: bit.ly/3DvTF8E #urology #oncology #SUI #incontinence #mRNA #clinicaldevelopment
1
1
153
@versameb CEO Klaas Zuideveld is to speak at tomorrow’s @DDWJournal webinar, "Where are the breakthroughs in mRNA drug discovery and development?" The webinar will take place on Wednesday 19 July at 4:00 PM to 5:00 PM BST. Register here: bit.ly/3XY7QNq #urology #mRNA
1
116
Load more